Apollo Endosurgery Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the fourth quarter 2022, Apollo Endosurgery Inc 's inventory turnover ratio sequentially decreased to 2.19 in the fourth quarter 2022, otherwise the ratio remained above the average, as APEN's markets remain strong.Apollo Endosurgery Inc 's average inventory processing period in the Dec 31 2022 quarter, has increased to 167 days, from 164 days, in the Sep 30 2022 quarter.

Within Healthcare sector 239 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1444 in the third quarter 2022, to 1606.

APEN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Apollo Endosurgery Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

APEN Inventory Turnover Ratio	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Inventory Growth	52.48 %	53.97 %	39.69 %	28.58 %	19.17 %
Y / Y Cost of Sales Growth	40.85 %	18 %	31.46 %	28.55 %	21.04 %
Inventory Turnover Ratio (TTM)	2.19	2.23	2.38	2.42	2.43
APEN's Total Ranking	# 1606	# 1444	# 1552	# 1444	# 1565
Average inventory processing period	167	164	154	151	150
Seq. Inventory Growth	9.28 %	13.33 %	11.18 %	10.74 %	10.35 %
Seq. Cost of Sales Growth	12.7 %	5.83 %	14.53 %	3.11 %	-5.58 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 96
Healthcare Sector	# 240
Overall Market	# 1606

Inventory Turnover Ratio Statistics
High	Average	Low
2.59	2.06	0.51
(Sep 30 2019)		(Mar 31 2018)

APEN Company Profile >> Back to APEN Efficiency Comparisons >> Compare APEN Inventory Turnover Ratio to its Competitors

Financial Statements
Apollo Endosurgery Inc 's Inventories	$ 18 Millions	Visit APEN's Balance sheet
Apollo Endosurgery Inc 's Cost of Revenues TTM	$ 34 Millions	Visit APEN's Income Statement
What are APEN's Sales?		Visit APEN's Sales by Segment

Other Inventory Turnover Ratios
Apollo Endosurgery Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
APEN's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for APEN's Competitors
Inventory Turnover Ratio for APEN's Suppliers
Inventory Turnover Ratio for APEN's Customers

You may also want to know
APEN's Sales Growth Rates	APEN's Pe Price to earnings ratio	APEN's Receivables Turnover Ratio	APEN's Stock Quote
APEN's Net Income Growth Rates	APEN's Ps Price to Sales ratio	APEN's Sales per Employee	APEN's Asset Turnover Ratio
APEN's Net Margin	APEN's Pb Price to Book ratio	APEN's Financial Strength Ratios	APEN's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Dec 31 2022	Inventories at quarter ending Dec 31 2022
Burning Rock Biotech Limited	5.19	$ 26.561 Millions	$ 5 Millions
Integer Holdings Corporation	5.17	$ 1,017.090 Millions	$ 197 Millions
Abbvie Inc	5.11	$ 17,414.000 Millions	$ 3,408 Millions
Exact Sciences Corporation	4.98	$ 574.394 Millions	$ 115 Millions
Opko Health Inc	4.97	$ 407.646 Millions	$ 82 Millions
Harrow Inc	4.76	$ 25.383 Millions	$ 5 Millions
Henry Schein Inc	4.72	$ 8,816.000 Millions	$ 1,869 Millions
Bristol myers Squibb Company	4.68	$ 10,137.000 Millions	$ 2,165 Millions
Horizon Therapeutics Public Limited Company	4.66	$ 920.197 Millions	$ 198 Millions
Incyte Corporation	4.66	$ 206.997 Millions	$ 44 Millions
Catalyst Pharmaceuticals Inc	4.65	$ 34.393 Millions	$ 7 Millions
Nexgel Inc	4.59	$ 1.792 Millions	$ 0 Millions
Catalent Inc	4.54	$ 3,325.300 Millions	$ 732 Millions
Precision Optics Corporation Inc	4.42	$ 12.798 Millions	$ 3 Millions
Steris Plc	4.41	$ 2,410.613 Millions	$ 547 Millions
Organogenesis Holdings Inc	4.40	$ 105.059 Millions	$ 24 Millions
T2 Biosystems Inc	4.36	$ 21.101 Millions	$ 5 Millions
Logicmark Inc	4.34	$ 4.686 Millions	$ 1 Millions
Alimera Sciences Inc	4.25	$ 7.977 Millions	$ 2 Millions
West Pharmaceutical Services Inc	4.23	$ 1,750.700 Millions	$ 414 Millions
Integrated Biopharma Inc	4.17	$ 48.036 Millions	$ 12 Millions
Teva Pharmaceutical Industries Limited	4.16	$ 7,952.000 Millions	$ 1,912 Millions
Myomo Inc	4.10	$ 5.302 Millions	$ 1 Millions
Rayont Inc	4.08	$ 1.868 Millions	$ 0 Millions
Steris Plc	4.07	$ 2,459.754 Millions	$ 604 Millions
Eargo Inc	4.07	$ 22.988 Millions	$ 6 Millions
Tandem Diabetes Care Inc	4.04	$ 388.231 Millions	$ 96 Millions
Idexx Laboratories Inc	4.02	$ 1,365.078 Millions	$ 339 Millions
Qiagen N v	4.01	$ 702.046 Millions	$ 175 Millions
Novocure Limited	4.00	$ 114.867 Millions	$ 29 Millions

Date modified: 2026-09-08T15:10:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.